SI-BONE, Inc.
No enriched coverage for $SIBN in the last 7 days.
No SEC Form 4 filings for $SIBN in the last 30 days.
SI-BONE (Nasdaq: SIBN) announced it will participate in the BofA Securities 2026 Healthcare Conference in Las Vegas, NV, on Tuesday, May 12, 2026. Management will host a fireside chat at 8:00 a.m. PT / 11:00 a.m. ET, with live audio available via webcast on the company’s investor relations page. The webcast will also be archived for at least 90 days for replay.
Impax Asset Management Group plc increased its stake in SiBone (NASDAQ:SIBN) by 17.1% in the fourth quarter, bringing their total holdings to $23.66 million. Other institutional investors have also adjusted their positions in SiBone, with 98.11% of the stock owned by institutional investors and hedge funds. Despite some insider selling, analysts maintain a "Moderate Buy" consensus rating for SiBone, with an average target price of $24.00.
American Century Companies Inc. increased its stake in SiBone (NASDAQ:SIBN) by 22.5%, acquiring an additional 521,683 shares and now holding a total of 2,838,107 shares valued at $41.8 million. SiBone reported a smaller-than-expected quarterly loss of $0.04 per share, beating estimates by $0.09, and generated revenues of $56.35 million. Analysts currently have a "Moderate Buy" rating for SiBone with a consensus target price of $24.67.
